Supernus announces Q3 2023 earnings release and call on Nov 8

SUPERNUS PHARMACEUTICALS, INC.

Earnings results after market close on Nov 8, 2023; call at 4:30 p.m. ET.
President/CEO Jack Khattar and CFO Tim Dec to host conference call.
No financial results disclosed; this is a scheduling announcement.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.7

SUPERNUS PHARMACEUTICALS, INC. reported financial results for the third quarter of 2023.

Period: the third quarter of 2023
Result: reported results

Exact text from the filing

Supernus Pharmaceuticals, Inc. issued a press release announcing that it expects to report its business results for the third quarter of 2023 after the market closes on Wednesday, November 8, 2023.

View on SEC.gov

Browse all earnings releases →

SUPERNUS PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001356576-23-000063

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.